Healthcare Industry News: HSMN NewsFeed
News Release - December 15, 2010
Pico-Tesla Starts Pilot Study of Magneceutical(R) Therapy For FibromyalgiaRandomized, double-blind, placebo-controlled study seeks to determine if magnetic fields using Company’s Resonator™ device can be an adjunctive therapy to oral medications for improving symptoms of fibromyalgia
CLEARWATER, Fla.--(Healthcare Sales & Marketing Network)-- Pico-Tesla, The Magneceutical® Company, announced today that it has commenced a randomized, double-blind, placebo-controlled pilot study of 30 patients who have fibromyalgia. The pilot study seeks to determine whether the application of magnetic fields generated by Pico-Tesla’s patented Resonator™ system can be effective as an adjunctive therapy to oral medications in ameliorating the symptoms of fibromyalgia.
The study will be coordinated by Miguel Trevino, M.D., Medical Director, Innovative Research of West Florida, Clearwater, Fla. Dr. Trevino is certified to practice medicine by the American Board of Internal Medicine. Innovative Research of West Florida is a leading Clinical Research Site.
“We are excited about expanding the clinical indications for Magneceutical® Therapy, and pleased to have Dr. Trevino coordinating our pilot study to establish the clinical potential of Magneceutical® Therapy for fibromyalgia patients,” said Allen Braswell, CEO of Pico-Tesla.
Fibromyalgia (pronounced fy-bro-my-AL-ja) is a common and complex chronic pain disorder that affects people physically, mentally and socially. Fibromyalgia, which has also been referred to as fibromyalgia syndrome, fibromyositis and fibrositis, is characterized by chronic widespread pain, multiple tender points, abnormal pain processing, sleep disturbances, fatigue and often psychological distress. For those with severe symptoms, fibromyalgia can be extremely debilitating and interfere with basic daily activities. (Source: National Fibromyalgia Association)
Pico-Tesla’s Magneceutical® Therapy involves the use of an extremely low-level electromagnetic field (EMF) applied by a specially designed device—the Resonator™, invented by Dr. Jerry I. Jacobson, along with proprietary therapeutic protocols—intended to improve a number of the signs and symptoms of fibromyalgia and other disorders and diseases, including atrial fibrillation, Parkinson’s disease, Alzheimer’s disease and osteoarthritis.
Privately held Pico-Tesla Magnetic Therapies is an emerging medical technology company with operations at: 7852 South Elati, Suite #202, Littleton, CO 80120 (303-795-3222); 4700 140th Avenue North, Suite #101, Clearwater, FL 33762; and, 27780 Novi Road, Suite 100, Novi, MI 48377 (248) 773-8969.
CAUTION: The Resonator™ device is an Investigational Device limited by federal (or United States) law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical® Therapy generally available outside of Investigational Review Board (IRB)-approved clinical studies.
Source: Pico-Tesla Magnetic Therapies
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.